Immune to Cancer: The CRI Blog
-
Skin Cancer Awareness Month: 2022 Immunotherapy Research Updates
This Skin Cancer Awareness month, discover new research, treatments, and progress for a future immune to skin…
-
FDA Approves New LAG-3 Checkpoint Inhibitor Immunotherapy Combination
Patients with unresectable or metastatic melanoma can now be treated with dual checkpoint blockade targeting the PD-1…
-
Skin Cancer Awareness Month: 2021 Immunotherapy Research Updates
This May for Skin Cancer Awareness Month, we look at new research, new treatments, and how we’re…
-
Skin Cancer Awareness Month: 2020 Immunotherapy Research Update
The changing treatment landscape, new scientific research, and how we’re working toward a future immune to skin…
-
Cemiplimab Becomes First Treatment Approved for Advanced Cutaneous Squamous Cell Carcinoma
Immunotherapy is now approved for patients with advanced forms of the second most common form of skin…
-
ASCO18 Recap: How Immunotherapy is Revolutionizing Cancer Treatment
Our recap of the immunotherapy highlights from the world’s largest clinical cancer conference in 2018